Copyright
©The Author(s) 2021.
World J Transplant. Jun 18, 2021; 11(6): 161-179
Published online Jun 18, 2021. doi: 10.5500/wjt.v11.i6.161
Published online Jun 18, 2021. doi: 10.5500/wjt.v11.i6.161
Figure 1 Metabolic liver disease.
A: Explant liver specimen of a case of tyrosinemia with nodules of varying sizes; B: Tyrosinemia liver with steatosis [hematoxylin and eosin (HE staining)]; C: Tyrosinemia liver with cirrhosis, hepatocellular ballooning, and fatty change (HE staining); D: Galactosemia with bridging fibrosis, bile ductular reaction, fatty change and rosetting (HE staining).
- Citation: Menon J, Vij M, Sachan D, Rammohan A, Shanmugam N, Kaliamoorthy I, Rela M. Pediatric metabolic liver diseases: Evolving role of liver transplantation. World J Transplant 2021; 11(6): 161-179
- URL: https://www.wjgnet.com/2220-3230/full/v11/i6/161.htm
- DOI: https://dx.doi.org/10.5500/wjt.v11.i6.161